Coherus Biosciences
Earnings Surprise
Analysts estimated CHRS earnings of $-0.30 per share this quarter (Q3). CHRS's actual earnings were $-0.33 per share.
CHRS EPS surprise of -11.56%Analysts estimated CHRS earnings of $-0.29 per share this quarter (Q2). CHRS's actual earnings were $-0.34 per share.
CHRS EPS surprise of -17.65%Analysts estimated CHRS earnings of $-0.22 per share this quarter (Q1). CHRS's actual earnings were $-0.35 per share.
CHRS EPS surprise of -59.60%Analysts estimated CHRS earnings of $-0.13 per share this quarter (Q4). CHRS's actual earnings were $-0.28 per share.
CHRS EPS surprise of -108.96%Analysts estimated CHRS earnings of $-0.14 per share this quarter (Q3). CHRS's actual earnings were $-0.01 per share.
CHRS EPS surprise of 92.65%Analysts estimated CHRS earnings of $-0.30 per share this quarter (Q2). CHRS's actual earnings were $-0.14 per share.
CHRS EPS surprise of 52.67%Analysts estimated CHRS earnings of $-0.25 per share this quarter (Q1). CHRS's actual earnings were $-0.32 per share.
CHRS EPS surprise of -29.76%Analysts estimated CHRS earnings of $-0.28 per share this quarter (Q3). CHRS's actual earnings were $-0.27 per share.
CHRS EPS surprise of -3.64%Analysts estimated CHRS earnings of $-0.28 per share this quarter (Q3). CHRS's actual earnings were $-0.27 per share.
CHRS EPS surprise of -3.64%